Related Experiment Video

Updated: Jun 7, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Insulin and β-adrenergic receptors inhibit retinal endothelial cell apoptosis through independent pathways

Surekha Rani Panjala1, Jena J Steinle

  • 1Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

Neurochemical Research
|November 6, 2010
PubMed

Insights

Beta-adrenergic receptors and insulin independently inhibit retinal endothelial cell apoptosis in high glucose conditions, offering new insights for diabetic retinopathy treatments.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Cell Biology

Background:

  • Diabetic retinopathy is linked to abnormal insulin receptor signaling.
  • Hyperglycemia impacts insulin signaling and β-adrenergic receptor interactions.
  • Retinal endothelial cell apoptosis is a key feature of diabetic retinopathy.

Purpose of the Study:

  • To investigate the synergistic effects of β-adrenergic receptor stimulation and insulin on retinal endothelial cell apoptosis under hyperglycemic conditions.
  • To determine the signaling pathways involved in these interactions.

Main Methods:

  • Human retinal endothelial cells were cultured in high glucose (25 mM) medium.
  • Cells were treated with a β-1-adrenergic receptor agonist (xamoterol) and/or insulin.
  • Levels of insulin receptor, IGF-1 receptor, Akt phosphorylation, and cleaved caspase 3 were assessed.

Main Results:

  • Xamoterol alone decreased insulin receptor, IGF-1 receptor, and Akt phosphorylation.
  • Insulin alone increased insulin receptor, IGF-1 receptor, and Akt phosphorylation.
  • Both xamoterol and insulin significantly inhibited retinal endothelial cell apoptosis, but via independent pathways.

Conclusions:

  • β-adrenergic receptors and insulin independently inhibit retinal endothelial cell apoptosis in hyperglycemia.
  • These findings suggest distinct molecular mechanisms for each pathway.
  • The results have potential implications for novel therapeutic strategies for diabetic retinopathy.

More Related Videos

Retinal Cryo-sections, Whole-Mounts, and Hypotonic Isolated Vasculature Preparations for Immunohistochemical Visualization of Microvascular Pericytes10:46

Retinal Cryo-sections, Whole-Mounts, and Hypotonic Isolated Vasculature Preparations for Immunohistochemical Visualization of Microvascular Pericytes

Published on: October 7, 2018

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...